v3.26.1
Equity Investments
9 Months Ended
Jun. 30, 2026
Schedule of Investments [Abstract]  
Equity Investments

Note 6 — Equity Investments

 

As of June 30, 2026 and September 30, 2025, equity investment consisted of the following:

 

  

June 30,

2026

  

September 30,

2025

 
   (unaudited)     
Aurora Technology Holding Limited  $1,000,000   $1,000,000 
Flower Mouse Network Technology Limited   1,200,000    1,200,000 
Total cost basis   2,200,000    2,200,000 
Less: impairment loss   (700,000)   - 
Carrying value  $1,500,000   $2,200,000 

 

 

On May 28, 2025, the Company entered into an equity investment agreement with Aurora Technology Holding Limited (“Aurora”), securing a 16.67% ownership interest in Aurora, and for which the Company does not have the ability to exercise significant influence. The investment totaled $1 million. The Company measure investments in equity investments without a readily determinable fair value using a measurement alternative that measures these securities at the cost method minus impairment, if any, plus or minus changes resulting from observable price changes on a non-recurring basis. A third-party independent appraiser was engaged to calculate pre-investment fair value of Aurora. Gains and losses on these securities are recognized in other income and expenses. For the nine months ended June 30, 2026 and 2025, impairment loss for Aurora amounted to $300,000 and $Nil, respectively.

 

On August 6, 2025, Lear Group Limited, the subsidiary of the Company, entered into an equity investment agreement with Flower Mouse Network Technology Limited (“Flower”), securing a 15% ownership interest in Flower, and for which the Company does not have the ability to exercise significant influence. The investment totaled $1.2 million. The Company measure investments in equity investments without a readily determinable fair value using a measurement alternative that measures these securities at the cost method minus impairment, if any, plus or minus changes resulting from observable price changes on a non-recurring basis. A third-party independent appraiser was engaged to calculate pre-investment fair value of Flower. Gains and losses on these securities are recognized in other income and expenses. For the nine months ended June 30, 2026 and 2025, impairment loss for Flower amounted to $400,000 and $Nil, respectively.

 

On February 2, 2026, the Company entered into an equity investment agreement with Megabyte Solutions Limited (“Megabyte”), securing a 14.28% ownership interest in Megabyte, and for which the Company does not have the ability to exercise significant influence. The investment totaled $3 million. The Company measure investments in equity investments without a readily determinable fair value using a measurement alternative that measures these securities at the cost method minus impairment, if any, plus or minus changes resulting from observable price changes on a non-recurring basis. Gains and losses on these securities are recognized in other income and expenses. On May 29, 2026, the Company entered into an equity transfer agreement with a third-party buyer, pursuant to which the Company sold all shares in Megabyte Solutions Limited, which represents 14.28% of the total issued share capital in Megabyte Solutions Limited, for an aggregate purchase price of $2,800,000.